[HTML][HTML] Insulin-like growth factor receptor signaling in tumorigenesis and drug resistance: a challenge for cancer therapy

H Hua, Q Kong, J Yin, J Zhang, Y Jiang - Journal of hematology & …, 2020 - Springer
Insulin-like growth factors (IGFs) play important roles in mammalian growth, development,
aging, and diseases. Aberrant IGFs signaling may lead to malignant transformation and …

[HTML][HTML] HER3 in cancer: from the bench to the bedside

L Gandullo-Sánchez, A Ocaña, A Pandiella - Journal of Experimental & …, 2022 - Springer
The HER3 protein, that belongs to the ErbB/HER receptor tyrosine kinase (RTK) family, is
expressed in several types of tumors. That fact, together with the role of HER3 in promoting …

[HTML][HTML] Role of drug catabolism, modulation of oncogenic signaling and tumor microenvironment in microbe-mediated pancreatic cancer chemoresistance

M Capula, M Perán, G Xu, V Donati, D Yee… - Drug Resistance …, 2022 - Elsevier
Pancreatic ductal adenocarcinoma (PDAC) has one of the highest incidence/death ratios
among all neoplasms due to its late diagnosis and dominant chemoresistance. Most PDAC …

Costs and causes of oncology drug attrition with the example of insulin-like growth factor-1 receptor inhibitors

V Jentzsch, L Osipenko, JW Scannell… - JAMA Network …, 2023 - jamanetwork.com
Importance The development of oncology drugs is expensive and beset by a high attrition
rate. Analysis of the costs and causes of translational failure may help to reduce attrition and …

[HTML][HTML] Gemcitabine resistance of pancreatic cancer cells is mediated by IGF1R dependent upregulation of CD44 expression and isoform switching

C Chen, S Zhao, X Zhao, L Cao, A Karnad… - Cell Death & …, 2022 - nature.com
Chemoresistance in pancreatic cancer cells may be caused by the expansion of inherently
resistant cancer cells or by the adaptive plasticity of initially sensitive cancer cells. We …

[HTML][HTML] Tumor microenvironment and metabolic remodeling in gemcitabine‐based chemoresistance of pancreatic cancer

Z Gu, Y Du, X Zhao, C Wang - Cancer Letters, 2021 - Elsevier
Pancreatic ductal adenocarcinoma (PDAC) is a solid malignant tumor with a very low
operative rate and a poor patient prognosis. Therefore, gemcitabine (GEM)-based …

[HTML][HTML] New insights into the role of adipocytes in pancreatic cancer progression: paving the way towards novel therapeutic targets

YC Lin, YC Hou, HC Wang, YS Shan - Theranostics, 2023 - ncbi.nlm.nih.gov
Pancreatic cancer (PC) remains one of the most lethal malignancies across the world, which
is due to delayed diagnosis and resistance to current therapies. The interactions between …

The RTK interactome: overview and perspective on RTK heterointeractions

MD Paul, K Hristova - Chemical reviews, 2018 - ACS Publications
Receptor tyrosine kinases (RTKs) play important roles in cell growth, motility, differentiation,
and survival. These single-pass membrane proteins are grouped into subfamilies based on …

[HTML][HTML] Curcumin and berberine co-loaded liposomes for anti-hepatocellular carcinoma therapy by blocking the cross-talk between hepatic stellate cells and tumor …

J Wu, C Qi, H Wang, Q Wang, J Sun, J Dong… - Frontiers in …, 2022 - frontiersin.org
Cancer-associated fibroblasts (CAFs) are a major component of the tumor microenvironment
(TME). In hepatocellular carcinoma (HCC), quiescent hepatic stellate cells (HSCs) could be …

[HTML][HTML] Drugging IGF-1R in cancer: New insights and emerging opportunities

P Wang, VCY Mak, LWT Cheung - Genes & diseases, 2023 - Elsevier
The insulin-like growth factor (IGF) axis plays important roles in cancer development and
metastasis. The type 1 IGF receptor (IGF-1R) is a key member in the IGF axis and has long …